Related Experiment Video
Updated: Aug 10, 2026

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
Published on: June 13, 2014
TGFbeta1 signaling via alphaVbeta6 integrin
Martin P Kracklauer1, Christian Schmidt, Guido M Sclabas
1Section of Molecular Cell and Developmental Biology, Institute for Cellular and Molecular Biology, The University of Texas at Austin, 1 University Station, A4800, 78712, Austin, TX, USA. mordechai30@hotmail.com
Background:
Transforming growth factor beta1 (TGFbeta1) is a potent inhibitor of epithelial cell growth, thus playing an important role in tissue homeostasis. Most carcinoma cells exhibit a reduced sensitivity for TGFbeta1 mediated growth inhibition, suggesting TGFbeta1 participation in the development of these cancers. The tumor suppressor gene DPC4/SMAD4, which is frequently inactivated in carcinoma cells, has been described as a key player in TGFbeta1 mediated growth inhibition. However, some carcinoma cells lacking functional SMAD4 are sensitive to TGFbeta1 induced growth inhibition, thus requiring a SMAD4 independent TGFbeta1 pathway.
Results:
Here we report that mature TGFbeta1 is a ligand for the integrin alphaVbeta6, independent of the common integrin binding sequence motif RGD. After TGFbeta1 binds to alphaVbeta6 integrin, different signaling proteins are activated in TGFbeta1-sensitive carcinoma cells, but not in cells that are insensitive to TGFbeta1. Among others, interaction of TGFbeta1 with the alphaVbeta6 integrin resulted in an upregulation of the cell cycle inhibitors p21/WAF1 and p27 leading to growth inhibition in SMAD4 deleted as well as in SMAD4 wildtype carcinoma cells.
Conclusions:
Our data provide support for the existence of an alternate TGFbeta1 signaling pathway that is independent of the known SMAD pathway. This alternate pathway involves alphaVbeta6 integrin and the Ras/MAP kinase pathway and does not employ an RGD motif in TGFbeta1-sensitive tumor cells. The combined action of these two pathways seems to be necessary to elicit a complete TGFbeta1 signal.
Insights
Transforming growth factor beta1 (TGFbeta1) signals through alphaVbeta6 integrin, independent of the SMAD pathway. This alternate pathway inhibits carcinoma cell growth, even in SMAD4-deficient cells, revealing a new target for cancer therapy.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Signaling
Background:
- Transforming growth factor beta1 (TGFbeta1) inhibits epithelial cell growth and maintains tissue homeostasis.
- Carcinoma cells often show reduced sensitivity to TGFbeta1, implicating it in cancer development.
- The tumor suppressor gene DPC4/SMAD4 is crucial for TGFbeta1 growth inhibition, but SMAD4-independent pathways exist.
Purpose of the Study:
- To investigate the SMAD4-independent TGFbeta1 signaling pathway in carcinoma cells.
- To identify novel ligands and mediators of TGFbeta1-induced growth inhibition.
Main Methods:
- Investigated TGFbeta1 binding to integrins.
- Analyzed signaling protein activation in response to TGFbeta1.
- Assessed the role of alphaVbeta6 integrin in TGFbeta1 signaling.
- Measured cell cycle inhibitor expression (p21/WAF1, p27) and cell growth.
Main Results:
- Mature TGFbeta1 directly binds to integrin alphaVbeta6, independent of the RGD motif.
- TGFbeta1-alphaVbeta6 interaction activates signaling proteins in TGFbeta1-sensitive carcinoma cells.
- This interaction upregulates cell cycle inhibitors p21/WAF1 and p27, inhibiting growth in both SMAD4-deleted and SMAD4-wildtype cells.
Conclusions:
- A SMAD4-independent TGFbeta1 signaling pathway involving alphaVbeta6 integrin exists.
- This pathway utilizes the Ras/MAP kinase pathway and does not require an RGD motif.
- Both SMAD-dependent and alphaVbeta6-mediated pathways are necessary for a complete TGFbeta1 signal.
More Related Videos
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
TGF - β Signaling Pathway
Activation and Inactivation of G Proteins
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions
Some...

